Medtronic plc (NYSE:MDT) Q4 2023 Earnings Conference Call May 25, 2023 8:00 AM ET
Company Participants
Ryan Weispfenning - VP, IR
Geoffrey Martha - Chairman & CEO
Karen Parkhill - CFO
Brad Welnick - IR
Que Dallara - EVP & President, Diabetes Operating Unit
Sean Salmon - EVP & President, Cardiovascular Portfolio
Brett Wall - EVP & President, Neuroscience Portfolio
Bob White - EVP & President, Medical Surgical Portfolio
Conference Call Participants
Robert Marcus - JPMorgan
Vijay Kumar - Evercore ISI
Larry Biegelsen - Wells Fargo
Matt Miksic - Barclays
Travis Steed - BofA
Matt O'Brien - Piper Sandler Companies
Peter Chickering - Deutsche Bank
Matt Taylor - Jefferies
Shagun Singh - RBC
Rich Newitter - Truist Securities
Joanne Wuensch - Citi
Anthony Petrone - Mizuho Securities
Ryan Weispfenning
Good morning, I'm Ryan Weispfenning, Vice President and Head of Medtronic Investor Relations. Welcome to Minnesota, land of 10,000 lakes. I appreciate that you're joining us today for Medtronic's Fiscal Year 2023 Fourth Quarter Earnings Video Webcast.
Before we go inside to hear our prepared remarks, I'll share a few details about today's webcast. Joining me are Geoff Martha, Medtronic Chairman and Chief Executive Officer; and Karen Parkhill, Medtronic Chief Financial Officer; Jeff and Karen will provide comments on the results of our fourth quarter and fiscal year 2023, which ended on April 28, 2023 and our outlook for fiscal year '24.
After our prepared remarks, the executive VPs from each of our four segments will join us, and we'll take questions from the sell-side analysts that cover the company. Today's program should last about an hour. Earlier this morning, we issued a press release containing our financial statements and divisional and geographic revenue summaries. We also posted an earnings presentation that provides additional details on our performance. The presentation can be accessed in our earnings press release
- Read more current MDT analysis and news
- View all earnings call transcripts